Allison B. Reiss is an Associate Professor in the Department of Medicine and Biomedical Research Institute, NYU Grossman Long Island School of Medicine, Mineola, NY, USA. She received her M.D. from SUNY Downstate School of Medicine and completed her Internal Medicine Residency at UMDNJ Rutgers. She is certified by the American Board of Internal Medicine. She is well-published in numerous medical and scientific journals and has chaired symposia at national and international conferences. She has received recognition and funding for her work from a number of organizations, including the Alzheimer’s Foundation of America, the American Heart Association, the National Institutes of Health, the Arthritis Foundation, and the Neuroscience Education and Research Foundation. Dr. Reiss is head of a laboratory studying the molecular mechanisms underlying Alzheimer's disease with a focus on finding new and effective treatments. She has a strong passion for community outreach and is dedicated to improving health care, especially for older populations.
Shelly Gulkarov is a student at Adelphi University, working toward a Bachelor of Science degree in Biology. She is an aspiring physician with a strong background in biomedical research. Ms. Gulkarov is currently a research intern at NYU Grossman Long Island School of Medicine and is involved in studying neurodegeneration in Alzheimer’s disease, traumatic brain injury and in prostate cancer patients treated with androgen blocking drugs. She hopes that her experience in research will better develop her understanding of the role of inflammation in the pathobiology of neurocognitive disorders as she pursues a career in medicine and biomedical research.
Ankita Srivastava is a Research Associate in the Inflammation Laboratory of Dr. Allison Reiss in the Department of Foundations of Medicine, NYU Grossman Long Island School of Medicine. She completed her Ph.D. in 2017 from CSIR-CDRI, India, working on adipose tissue insulin resistance and non-alcoholic fatty liver diseases. She joined NYU in 2018 as a post-doctoral fellow studying a Roux-en-Y gastric bypass model of bariatric surgery in mice. She joined the Reiss lab in April 2023 and, since then, has focused on designing new and effective treatments for neurocognitive disorders, such as Alzheimer’s disease and those induced by hormone deprivation. Her specific interest is in determining the molecular mechanisms underlying mitochondrial dysfunction that leads to neuronal death. She is also involved in a project characterizing the role of adipose tissue-derived exosomal microRNAs in cardiovascular disease. She has authored numerous publications in high-impact, peer-reviewed journals and presented posters and oral presentations at various
conferences.
Aaron Pinkhasov, M.D., is the Founding Chair of the Behavioral Health Department at NYU Langone Hospital—Long Island and is a Clinical Professor of Psychiatry and Medicine at NYU Grossman Long Island School of Medicine. He completed a combined Internal Medicine and Psychiatry Residency program at SUNY Downstate in Brooklyn, New York in 2001, after which he served as Chief Resident in Internal Medicine at Kings County Hospital, Brooklyn, New York. Prior to NYU-Long Island, he was on faculty at Downstate Medical Center and has led the Department of Psychiatry and Neurology at Kingsbrook Jewish Medical Center in Brooklyn, NY from 2001 until 2014. The author of multiple publications and presentations, he has received several professional honors, including the President’s Award from the Office of the President, Borough of Brooklyn, Distinguished Recognition Award for Dedication and Commitment to Psychiatric Residency Education in Geriatric Psychiatry 2002-2014 from SUNY Downstate Medical Center, and Innovative Model for Integrated Care Award from the Association of Medicine and Psychiatry in 2017. He is a Distinguished Fellow of the American Psychiatric Association, a Fellow of the Academy of Consultation and Liaison Psychiatry, and a member of the Psychosomatic Committee at the Group for Advancement of Psychiatry. His areas of research include psychopharmacology and neurocognitive disorders, as well as the role of psychiatry service in optimizing health outcomes.
Irving H. Gomolin is a Professor at the Department of Medicine at NYU Grossman Long Island School of Medicine. He earned his MD from McGill University in 1976, completed his Residency in Internal Medicine at Jewish General Hospital in 1978, Fellowship at Brigham and Women’s Hospital/Harvard Medical School in 1980, and Residency in Internal Medicine at Beth Israel Hospital in 1981. At NYU Langone Hospital—Long Island, he works with a team of experts who are highly trained in the special needs of older people. Their team is supported by social workers, psychologists, and pharmacy specialists. When their patients require hospitalization or are in a nursing home, they often provide care at those sites to provide streamlined care for people. He has achieved fellowship status in internal medicine, clinical pharmacology, and geriatric medicine by their respective societies. His research has focused on medication issues in older people, the effects of vaccines, and system management.
Mark M. Stecker received his Ph.D. in physics at the University of Pennsylvania and his M.D. degree at Harvard, completed a residency in neurology at the University of Pennsylvania followed by a neuroscience/epilepsy fellowship. He has had a number of leadership positions in neurology, including founding chair of neuroscience at Winthrop University Hospital, and is now president of the Fresno Institute of Neuroscience, which is focused on clinical care in neurology and neurophysiology as well as research in neuroscience.
Thomas Wisniewski is a professor at the NYU Grossman School of Medicine and the director of NYU Langone’s Alzheimer’s Disease Research Center and its Center for Cognitive Neurology. Also, as the director of the New York State Center of Excellence for Alzheimer’s Disease at the Pearl I. Barlow Center for Memory Evaluation and Treatment, he evaluates patients who have a
variety of cognitive disorders. These include mild cognitive impairment, Alzheimer’s disease, Parkinson’s disease dementia, dementia with Lewy bodies, frontotemporal dementia, and Creutzfeldt-Jakob disease. He obtained his MD at King’s College London GKT School of Medical Education and completed his residencies and chief residencies in neurology and neuropathology at NYU School of Medicine and New York-Presbyterian/Columbia University Medical Center, respectively. For more than 30 years, he has been studying Alzheimer’s disease and related types of dementia, with continuous funding from the National Institutes of Health. His work has contributed to the development of novel biomarkers and therapeutic approaches to Alzheimer’s disease. He is currently studying a medication that stimulates immune system cells to eliminate the brain lesions associated with Alzheimer’s disease. In addition, he received the Alzheimer’s Association’s Zenith Fellows Award, which funds innovative scientific research.
Joshua De Leon is a Professor at the Department of Medicine and Biomedical Research Institute, NYU Grossman Long Island School of Medicine, Mineola, NY, USA. He received his B.A. in Biology and Philosophy from Franklin and Marshall College in 1984 and his M.D. from SUNY Downstate School of Medicine in 1988. He completed a residency in internal medicine and a fellowship in clinical and molecular cardiology at the Albert Einstein College of Medicine. He is a practicing cardiologist with extensive clinical experience in managing patients with inflammatory mechanisms underlying their cardiovascular disease and patients with disordered lipid metabolism. He has been a co-investigator on an American Heart Association-funded study of inflammation in cardiovascular disease and has participated as a site investigator for multiple clinical trials addressing acute coronary syndromes, chronic CAD management, and lipid metabolism and management. He has been listed in Castle Connolly’s “Top Doctors” series for the New York metro area.
